Skip to main content

CAPITAL COUNSEL LLC/NY

Position in GILD — Gilead Sciences, Inc.

CIK 1114928 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$8,708,363
-$898,132 QoQ
Shares Held
68,928
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#454
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CAPITAL COUNSEL LLC/NY holds $16,265,242 across 4 Drug Manufacturers - General names. GILD ranks #1 (53.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GILD
Gilead Sciences, Inc.
This page
68,928 $8,708,363

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,708,363 68,928
2026-03-31 $9,606,495 68,928
2025-12-31 $8,494,835 69,210
2025-09-30 $7,682,310 69,210
2025-06-30 $7,673,312 69,210
2025-03-31 $7,636,431 68,152
2024-12-31 $6,295,200 68,152
2024-09-30 $5,810,950 69,310
2024-06-30 $4,755,359 69,310
2024-03-31 $5,076,957 69,310
2023-12-31 $5,614,803 69,310
2023-09-30 $5,194,091 69,310
2023-06-30 $5,341,721 69,310
2023-03-31 $5,817,358 70,114
2022-12-31 $6,019,286 70,114
2022-09-30 $4,325,332 70,114
2022-06-30 $4,333,746 70,114
2022-03-31 $4,168,277 70,114
2021-12-31 $5,090,977 70,114
2021-09-30 $4,897,462 70,114
2021-06-30 $4,818,409 69,974
2021-03-31 $4,522,419 69,974
2020-12-31 $4,071,208 69,880
2020-09-30 $4,415,717 69,880
2020-06-30 $5,376,567 69,880
2020-03-31 $5,224,228 69,880